U.S. flag

An official website of the United States government

NM_031448.6(C19orf12):c.161G>T (p.Gly54Val) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 1, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000486662.3

Allele description [Variation Report for NM_031448.6(C19orf12):c.161G>T (p.Gly54Val)]

NM_031448.6(C19orf12):c.161G>T (p.Gly54Val)

Gene:
C19orf12:chromosome 19 open reading frame 12 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q12
Genomic location:
Preferred name:
NM_031448.6(C19orf12):c.161G>T (p.Gly54Val)
HGVS:
  • NC_000019.10:g.29702977C>A
  • NG_031970.2:g.17813G>T
  • NM_001031726.4:c.161G>T
  • NM_001256046.3:c.161G>T
  • NM_001256047.2:c.161G>T
  • NM_001282929.1:c.-32G>T
  • NM_001282930.3:c.-32G>T
  • NM_001282931.3:c.-32G>T
  • NM_031448.6:c.161G>TMANE SELECT
  • NP_001026896.2:p.Gly65Val
  • NP_001026896.3:p.Gly54Val
  • NP_001242975.1:p.Gly54Val
  • NP_001242976.1:p.Gly54Val
  • NP_113636.2:p.Gly54Val
  • NC_000019.9:g.30193884C>A
  • NM_001031726.3:c.194G>T
  • NM_031448.4:c.161G>T
Protein change:
G54V
Links:
dbSNP: rs752450983
NCBI 1000 Genomes Browser:
rs752450983
Molecular consequence:
  • NM_001282929.1:c.-32G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001282930.3:c.-32G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001282931.3:c.-32G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001031726.4:c.161G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001256046.3:c.161G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001256047.2:c.161G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_031448.6:c.161G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000573899GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Oct 1, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000573899.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.194 G>T variant in the C19orf12 gene has been previously reported in the homozygous state, and in the presence of a loss of function C19orf12 variant, in two unrelated sets of affected siblings with mitochondrial membrane protein-associated neurodegeneration (MPAN) (Hogarth et al., 2013; Yoganathan et al., 2016). This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). In-silico splice prediction models predict that c.194 G>T may weaken the natural splice acceptor site for intron 2. However, in the absence of RNA/functional studies, the effect of the c.194 G>T change in this individual is unknown. If c.194 G>T does not alter splicing, it will result in the G65V missense change. The G65V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position within a transmembrane domain that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret the c.194 G>T variant as a likely pathogenic variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024